Clinical Transplantation最新文献

筛选
英文 中文
Increased Risk of Pneumonia Among Patients With HeartMate 3 LVAD as Bridge to Heart Transplantation. 心脏伴侣3型左心室辅助器作为心脏移植桥梁的患者肺炎风险增加
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70746
Devin Mantini, Bana Hadid, Gabriel Dardik, Jose Fernandez, Boaz Elad, Brian LaBarre, Julia Baranowska, Adi Hertz, Salwa Rahman, Andrea Fernandez Valledor, Ersilia M DeFilippis, Paolo Colombo, Melana Yuzefpolskaya, Dor Lotan, Adil Yunis, Jayant Raikhelkar, Farhana Latif, Koji Takeda, Kevin Clerkin, Gabriel Sayer, Nir Uriel
{"title":"Increased Risk of Pneumonia Among Patients With HeartMate 3 LVAD as Bridge to Heart Transplantation.","authors":"Devin Mantini, Bana Hadid, Gabriel Dardik, Jose Fernandez, Boaz Elad, Brian LaBarre, Julia Baranowska, Adi Hertz, Salwa Rahman, Andrea Fernandez Valledor, Ersilia M DeFilippis, Paolo Colombo, Melana Yuzefpolskaya, Dor Lotan, Adil Yunis, Jayant Raikhelkar, Farhana Latif, Koji Takeda, Kevin Clerkin, Gabriel Sayer, Nir Uriel","doi":"10.1111/ctr.70746","DOIUrl":"https://doi.org/10.1111/ctr.70746","url":null,"abstract":"<p><strong>Background: </strong>Left ventricular assist devices (LVADs) are commonly used as a bridge to heart transplantation (HT). The HeartMate 3 (HM3) LVAD's proximity to the lung may expose patients to pulmonary complications during explantation. This study aimed to assess the risk of pneumonia following HT among HM3 patients bridged to HT.</p><p><strong>Methods: </strong>We retrospectively analyzed all adults who underwent HT at NYP-Columbia between 2016-2022. Patients bridged with HM3 LVAD were compared to controls bridged to HT without LVAD. The primary outcome was pneumonia incidence during index hospitalization. Categorical data were compared using Fisher and Wilcoxon tests. Multivariable logistic regression identified predictors of pneumonia.</p><p><strong>Results: </strong>281 patients were included, 82 with HM3 and 199 controls. Average age at HT and race were similar between groups. HM3 patients had more males and COPD/asthma, though less pulmonary hypertension. HM3 patients had a 79% increase in pneumonia incidence during index hospitalization (43% vs. 24%, p = 0.004) and an 83% increase in pneumonia incidence up to one year post-HT (55% vs. 30%, p = 0.001). HM3 patients had longer intensive care unit stays and mechanical ventilation duration. After adjustment, HM3 remained an independent predictor of post-HT pneumonia (OR 2.19; 95% CI 1.21-3.99; p = 0.010). Among HM3 patients, prior coronary artery bypass graft was an additional risk factor for post-HT pneumonia.</p><p><strong>Conclusion: </strong>HM3 as bridge to HT is associated with an increased risk of post-HT pneumonia. Given these findings, enhanced antimicrobial prophylaxis and surgical techniques warrant further investigation.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Absolute Donor-Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study. 绝对供体-受体血清钠差异预测肝移植术后早期同种异体移植物功能障碍:一项回顾性队列研究。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70628
Wanzhen Cai, Rongping Chen, Xiayan Qian, Ka Yin Lui, Huan Ma, Changjie Cai
{"title":"Absolute Donor-Recipient Serum Sodium Difference Predicts Early Allograft Dysfunction After Liver Transplantation: A Retrospective Cohort Study.","authors":"Wanzhen Cai, Rongping Chen, Xiayan Qian, Ka Yin Lui, Huan Ma, Changjie Cai","doi":"10.1111/ctr.70628","DOIUrl":"https://doi.org/10.1111/ctr.70628","url":null,"abstract":"<p><strong>Background: </strong>Serum sodium level serves as an important indicator for evaluating marginal liver grafts. However, the relationship between the donor‑recipient serum sodium difference and recipient prognosis after liver transplantation remains insufficiently investigated. This study aimed to determine whether the donor‑recipient serum sodium difference predicts early allograft dysfunction (EAD) and patient survival following liver transplantation.</p><p><strong>Methods: </strong>In this retrospective cohort study, we included 214 donor‑recipient pairs who underwent liver transplantation at the First Affiliated Hospital of Sun Yat‑sen University between January 2018 and July 2023. Multivariate logistic regression analysis was performed to identify risk factors for EAD. The predictive performance of the donor‑recipient serum sodium difference was evaluated using receiver operating characteristic (ROC) curves. Based on the optimal cut‑off value of 9.5 mmol/L, patients were categorized into high‑ and low‑sodium difference groups. Postoperative outcomes, liver function recovery, and survival were compared between the two groups.</p><p><strong>Results: </strong>The donor‑recipient serum sodium difference was significantly associated with the risk of EAD (OR  =  1.030, 95% CI: 1.004-1.056, P  <  0.05). Its predictive performance for EAD (AUC  =  0.618) was superior to that of donor serum sodium alone (AUC  =  0.597). Using the 9.5 mmol/L cut‑off, the high‑difference group (n  =  69) exhibited significantly higher incidences of EAD (44.92% vs. 26.90%), 30‑day mortality (11.59% vs. 2.76%), and 1‑year mortality (18.84% vs. 8.28%) compared with the low‑difference group (n  =  145) (all P  <  0.05). The high‑difference group also showed delayed recovery of postoperative liver function and significantly poorer graft and patient survival (Log‑rank P  <  0.05).</p><p><strong>Conclusion: </strong>The absolute donor‑recipient serum sodium difference independently predicts early allograft dysfunction and short‑term mortality after liver transplantation, providing valuable information for clinical risk stratification and prognostic assessment.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor on: Predictive Value of HLA-Derived T-Cell Epitope and B-Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes. 致编辑的信:hla衍生的t细胞表位和b细胞表位匹配算法对胰腺移植结果的预测价值。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70750
Muqadas Sultana, Mirza Faaz Baig
{"title":"Letter to the Editor on: Predictive Value of HLA-Derived T-Cell Epitope and B-Cell Epitope Matching Algorithms for Pancreas Transplant Outcomes.","authors":"Muqadas Sultana, Mirza Faaz Baig","doi":"10.1111/ctr.70750","DOIUrl":"https://doi.org/10.1111/ctr.70750","url":null,"abstract":"","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Fair Share? Early Changes in Pediatric Lung Transplantation in the Composite Allocation Score Era. 公平分配?复合分配评分时代儿童肺移植的早期变化。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70747
Alexandria L Soto, Isaac S Alderete, Mary Moya-Mendez, Haoran Jiang, Samantha E Halpern, Ewout Muylle, Kentaro Nakata, Kunal J Patel, Jacob Klapper, Hiroshi Date, Matthew G Hartwig
{"title":"A Fair Share? Early Changes in Pediatric Lung Transplantation in the Composite Allocation Score Era.","authors":"Alexandria L Soto, Isaac S Alderete, Mary Moya-Mendez, Haoran Jiang, Samantha E Halpern, Ewout Muylle, Kentaro Nakata, Kunal J Patel, Jacob Klapper, Hiroshi Date, Matthew G Hartwig","doi":"10.1111/ctr.70747","DOIUrl":"https://doi.org/10.1111/ctr.70747","url":null,"abstract":"<p><strong>Objective: </strong>In March 2023, the Composite Allocation Score (CAS) was introduced to address lung allocation disparities. While CAS outcomes have been reported in adults, its impact on pediatric candidates is poorly examined. This study compares pediatric recipient, donor, and transplant characteristics before and after CAS, with particular attention given to waitlist outcomes and transplantation rates.</p><p><strong>Methods: </strong>The UNOS registry was queried for pediatric lung transplant recipients (<18 years) between June 2021 and December 2024. Continuous variables were analyzed using student-t or Wilcoxon tests, and categorical with Fisher's exact. Survival was analyzed using Kaplan-Meier curves.</p><p><strong>Results: </strong>Eighty-two pediatric lung transplant recipients were identified (Pre-CAS = 36; Post-CAS = 46). In the Post-CAS era, pediatric lung transplant rate increased (103.5 vs. 240.0 transplants per 100 patient-years; p<0.001), median donor age increased (14.0 vs. 19.5 years; p = 0.0003), median waitlist time decreased (74 days vs. 149 days; p = 0.023), median travel distance increased (388.5 vs. 428.0 miles; p = 0.21), and ischemic time increased (5.7 vs. 6.3 h; p = 0.014). However, graft survival at six months was not significantly different between eras (LAS = 91.7% vs. CAS = 83.7%; p = 0.30).</p><p><strong>Conclusion: </strong>Implementation of continuous distribution was associated with a higher transplant rate and shorter waitlist times in pediatric lung transplantation. Graft survival did not worsen under CAS, despite increased median travel distance and ischemic times.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care 有肥胖和代谢风险的活体肝供者:供者分类和护理的综述和指导。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-28 DOI: 10.1111/ctr.70681
Hyosun Han, Kristina Rachel Chacko, Babak. Orandi, Dagny E. von Ahrens, Alexandra Shingina, Susan C. Kim, Kymberly D. Watt, AnnMarie Liapakis, NALLDIG Consortium
{"title":"Living Liver Donors With Obesity and Metabolic Risk: Review and Guidance on Donor Triage and Care","authors":"Hyosun Han,&nbsp;Kristina Rachel Chacko,&nbsp;Babak. Orandi,&nbsp;Dagny E. von Ahrens,&nbsp;Alexandra Shingina,&nbsp;Susan C. Kim,&nbsp;Kymberly D. Watt,&nbsp;AnnMarie Liapakis,&nbsp;NALLDIG Consortium","doi":"10.1111/ctr.70681","DOIUrl":"10.1111/ctr.70681","url":null,"abstract":"<div>\u0000 \u0000 <p>With the increasing prevalence of obesity in the United States, potential living liver donors (LLDs) are similarly impacted. Historically, LLDs with obesity are deemed too high risk for donation due to concern for hepatic steatosis (HS) or post-surgical complications. Evolving data show that obesity is not the absolute indicator of HS and metabolic risk. Instead, distribution of fat in the visceral area as well as body composition drive the risk for metabolic dysfunction associated steatotic liver disease (MASLD). Prior practice patterns of denial of obese LLDs with metabolic risk require a change in mindset from the liver transplant community with a thoughtful, individualized risk assessment of all LLDs. By losing weight utilizing various dietary and procedural strategies, these “gray zone” LLDs improve their metabolic risk profile and can move into a low risk “green zone”, thus expanding the donor pool. Little data exist whether “gray zone” LLDs who succeed in weight loss have long-term consequences to their own health if they regain their weight or the clinical impact on their LDLT recipients. Ethical and financial questions remain as to the LDLT centers’ direct responsibility to maintaining donor health. Future studies evaluating interventions and outcomes are needed.</p>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149285807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of MELD 3.0 Score on Outcomes After Combined Heart–Liver Transplantation: A UNOS Database Analysis MELD 3.0评分对心脏-肝联合移植后预后的影响:UNOS数据库分析。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-11 DOI: 10.1111/ctr.70713
Gabriel Esmailian, Sangrag Ganguli, Richard Jiang, Alejandro Alvarez Lobo, Oliver Jawitz, Divyam Goel, Chetan Patel, Adam DeVore, Stuart Russell, Matthew Kappus, Lindsay King, Stuart Knechtle, Debra Sudan, Jeffrey Keenan, Jacob Schroder, Carmelo Milano
{"title":"Impact of MELD 3.0 Score on Outcomes After Combined Heart–Liver Transplantation: A UNOS Database Analysis","authors":"Gabriel Esmailian,&nbsp;Sangrag Ganguli,&nbsp;Richard Jiang,&nbsp;Alejandro Alvarez Lobo,&nbsp;Oliver Jawitz,&nbsp;Divyam Goel,&nbsp;Chetan Patel,&nbsp;Adam DeVore,&nbsp;Stuart Russell,&nbsp;Matthew Kappus,&nbsp;Lindsay King,&nbsp;Stuart Knechtle,&nbsp;Debra Sudan,&nbsp;Jeffrey Keenan,&nbsp;Jacob Schroder,&nbsp;Carmelo Milano","doi":"10.1111/ctr.70713","DOIUrl":"10.1111/ctr.70713","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Combined heart-liver transplantation (CHLT) is performed for select patients with end-stage heart and liver disease, though the prognostic value of the Model for End-Stage Liver Disease (MELD) score in this population remains unclear.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We evaluated adult CHLT recipients between March 2005 and May 2025 from the United Network for Organ Sharing database. Groups were stratified by MELD 3.0 score at transplant: 1–14 (Low), 15–24 (Medium), ≥25 (High). Kaplan-Meier analyses assessed overall survival and freedom from liver graft failure, and Cox proportional hazards analysis evaluated risk factors for mortality after CHLT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 601 CHLT patients, there were 231 Low MELD, 314 Medium MELD, and 56 High MELD. Kaplan Meier analyses showed no difference in survival or liver graft failure between the groups (<i>p</i> = 0.22 and <i>p</i> = 0.22, respectively). One-year survival for the Low, Med, and High MELD groups was 82.6% [95% CI 77.8%–87.8%], 82.6% [95% CI 78.4%–87.0%], and 90.2% [95% CI 82.4%–98.8%], respectively. Five-year survival for the Low, Med, and High MELD groups was 73.8% [95% CI 67.6%–80.5%], 76.9% [95% CI 71.9%–82.1%], and 82.0% [95% CI 71.2%–94.5%], respectively. Cox proportional hazards analysis did not show MELD 3.0 score as a risk factor for mortality after CHLT (HR 0.98, 95% CI 0.94%–1.01; <i>p</i> = 0.144).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>CHLT recipients have comparable long-term survival and liver graft failure rates regardless of MELD 3.0 score. For all three groups, mortality risk is greater during the first year. These findings suggest that MELD 3.0 may have limited prognostic utility in CHLT and support continued consideration of combined transplantation in appropriately selected patients despite elevated MELD 3.0 scores.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients—Results From Two Randomized Controlled Trials 心脏移植受者从钙调磷酸酶抑制剂到依维莫司的早期和晚期转换后左心室肿块的发展——来自两项随机对照试验的结果
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-09 DOI: 10.1111/ctr.70705
Klaus Murbraech, Feben Tecklzig, Richard John Massey, Einar Gude, Finn Gustafsson, Hans Eiskjær, Kristjan Karason, Göran Rådegran, Arne K. Andreassen, Lars Gullestad, Kaspar Broch
{"title":"Development in Left Ventricular Mass After Early and Late Conversion From Calcineurin Inhibitors to Everolimus in Heart Transplant Recipients—Results From Two Randomized Controlled Trials","authors":"Klaus Murbraech,&nbsp;Feben Tecklzig,&nbsp;Richard John Massey,&nbsp;Einar Gude,&nbsp;Finn Gustafsson,&nbsp;Hans Eiskjær,&nbsp;Kristjan Karason,&nbsp;Göran Rådegran,&nbsp;Arne K. Andreassen,&nbsp;Lars Gullestad,&nbsp;Kaspar Broch","doi":"10.1111/ctr.70705","DOIUrl":"https://doi.org/10.1111/ctr.70705","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Left ventricular hypertrophy in heart transplant recipients has been attributed to the use of calcineurin inhibitors. We assessed left ventricular mass across treatment arms in 83 heart transplant recipients in the Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE), and in 75 maintenance recipients in the Nordic Certican Trial in Heart and Lung Transplantation (NOCTET). In SCHEDULE, we randomized participants to treatment with calcineurin inhibitors or replacement with everolimus within 7–11 weeks after transplant. In NOCTET, participants were randomized to treatment with calcineurin inhibitors or a combination of low dose calcineurin inhibitors and everolimus. We followed patients with echocardiography for 3 years in the SCHEDULE trial and for 5 years in NOCTET. In SCHEDULE, left ventricular mass diminished with time, particularly across the first year of follow-up (everolimus arm: −10 ± 18 g/m<sup>2</sup>, cyclosporine arm: −9 ± 13 g/m<sup>2</sup>). However, there was no between-group difference in this development (<i>p</i> = 0.91). In NOCTET, there was no significant change in LVM over time and no between-group difference in the change (<i>p</i> = 0.27). In conclusion, <b>t</b>he replacement of calcineurin inhibitors with everolimus or a reduction in the calcineurin inhibitor dose did not mitigate left ventricular hypertrophy after heart transplantation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Trial Registration</h3>\u0000 \u0000 <p>SCHEDULE—ClinicalTrials.gov Identifier: NCT01266148; NOCTET—ClinicalTrials.gov Identifier: NCT00377962</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70705","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149146368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and Factors of Bacterial Zoonotic Infection in Solid Organ Transplant Recipients 实体器官移植受者细菌性人畜共患感染的发生率及影响因素。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-08 DOI: 10.1111/ctr.70708
Chia-Yu Chiu, Supavit Chesdachai, Deepali Boothankad Sharath, Zachary A. Yetmar, Andrés F. Henao-Martínez
{"title":"Incidence and Factors of Bacterial Zoonotic Infection in Solid Organ Transplant Recipients","authors":"Chia-Yu Chiu,&nbsp;Supavit Chesdachai,&nbsp;Deepali Boothankad Sharath,&nbsp;Zachary A. Yetmar,&nbsp;Andrés F. Henao-Martínez","doi":"10.1111/ctr.70708","DOIUrl":"10.1111/ctr.70708","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Infection remains a leading cause of morbidity and mortality among solid organ transplant (SOT) recipients, yet zoonotic pathogens as a distinct category remain underrecognized. We investigated the incidence, and risk factors of bacterial zoonotic infections after transplantation using a large multicenter database.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We queried the TriNetX database in from 2014–2024 to identify adult SOT recipients who developed bacterial zoonotic infections. We identified twelve bacterial zoonoses using ICD-10 codes: anthrax, brucellosis, cat scratch disease, glanders, leprosy, leptospirosis, tularemia, parrot fever, pasteurellosis, plague, Q fever, and rat-bite fever.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixty-one SOT recipients (0.03%) developed a bacterial zoonotic infection, corresponding to an incidence of 4.87 per 100 000 person-years. The median time from transplantation to infection was 736 days (IQR, 298–1970), with 72.1% of infections occurring more than one year after transplantation. The hospitalization rate was 41.0%, and the 90-day all-cause mortality rate was 6.6%. The three most common infections were Q fever, cat scratch disease, and pasteurellosis. No cases of anthrax, tularemia, plague, or rat-bite fever were identified. Black recipients had a 49% lower risk of bacterial zoonotic infection than White recipients.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Bacterial zoonotic infections were uncommon and occurred predominantly during the late post-transplant period. The lower risk observed among Black recipients reflects differences in animal and environmental exposure that this study could not measure, rather than biological susceptibility. Animal safety counseling should extend beyond the early post-transplant period and continue as part of long-term post-transplant care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical and Clinical Outcomes of Kidney Transplantation in Obese Recipients: A Single-Center Retrospective Study from Switzerland 肥胖肾移植受者的手术和临床结果:来自瑞士的单中心回顾性研究。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-06 DOI: 10.1111/ctr.70709
Eliot Melera, Lorenzo Costa, Céline Deslarzes-Dubuis, Sébastien Déglise, Alban Longchamp, Matthieu Halfon, Jean-Pierre Venetz, Dela Golshayan, Manuel Pascual, Maurice Matter, Tobias Zingg, David Martin
{"title":"Surgical and Clinical Outcomes of Kidney Transplantation in Obese Recipients: A Single-Center Retrospective Study from Switzerland","authors":"Eliot Melera,&nbsp;Lorenzo Costa,&nbsp;Céline Deslarzes-Dubuis,&nbsp;Sébastien Déglise,&nbsp;Alban Longchamp,&nbsp;Matthieu Halfon,&nbsp;Jean-Pierre Venetz,&nbsp;Dela Golshayan,&nbsp;Manuel Pascual,&nbsp;Maurice Matter,&nbsp;Tobias Zingg,&nbsp;David Martin","doi":"10.1111/ctr.70709","DOIUrl":"10.1111/ctr.70709","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The impact of recipient obesity on kidney transplant outcomes remains controversial. This study aimed to assess the effect of recipient obesity on short- and long-term outcomes following kidney transplantation (KT).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This single-center retrospective cohort study included all consecutive adult patients who underwent KT between January 1999 and December 2023 at the Transplantation Center of Lausanne University Hospital (CHUV), Lausanne, Switzerland. Surgical complications, delayed graft function (DGF), and graft survival were compared between obese (BMI ≥ 30 kg/m<sup>2</sup>) and non-obese recipients (BMI &lt; 30 kg/m<sup>2</sup>).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 953 patients were included, of whom 150 (16%) were obese. Obesity was associated with higher rates of surgical site infections (11% vs. 3%, <i>p</i> &lt; 0.001), overall infections (29% vs. 5%, <i>p</i> &lt; 0.001), lymphoceles (18% vs. 10%, <i>p</i> = 0.007), and incisional hernias (10% vs. 5%, <i>p</i> = 0.032). Length of hospital stay (19 vs. 17 days, <i>p</i> = 0.038) and DGF rates (21% vs. 14%, <i>p</i> = 0.024) were also higher in obese recipients. Patient survival (HR 1.09, 95% CI 0.59–1.99; <i>p</i> = 0.766) and death-censored graft survival (HR 0.92, 95% CI 0.29–2.92; <i>p</i> = 0.886) were comparable between groups at a median follow-up of 7.3 years (IQR, 3.3–12.4).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Recipient obesity was associated with an increased risk of surgical complications and DGF, resulting in longer hospital stays. However, it did not adversely affect long-term patient or graft survival. Therefore, despite higher early complications, obesity should not be considered a contraindication to KT.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vanishing Bronchus Syndrome After Lung Transplantation: Clinical Characteristics, Airway Colonization, and Stent Outcomes 肺移植后支气管消失综合征:临床特征、气道定植和支架结果。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-10-06 DOI: 10.1111/ctr.70707
Hirotsugu Notsuda, Sakiko Kumata, Ken Onodera, Tatsuaki Watanabe, Yui Watanabe, Takashi Hirama, Takaya Suzuki, Hisashi Oishi, Yoshinori Okada
{"title":"Vanishing Bronchus Syndrome After Lung Transplantation: Clinical Characteristics, Airway Colonization, and Stent Outcomes","authors":"Hirotsugu Notsuda,&nbsp;Sakiko Kumata,&nbsp;Ken Onodera,&nbsp;Tatsuaki Watanabe,&nbsp;Yui Watanabe,&nbsp;Takashi Hirama,&nbsp;Takaya Suzuki,&nbsp;Hisashi Oishi,&nbsp;Yoshinori Okada","doi":"10.1111/ctr.70707","DOIUrl":"10.1111/ctr.70707","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Airway complications remain a significant cause of morbidity after lung transplantation. Among them, vanishing bronchus syndrome (VBS) represents a severe form of airway injury characterized by progressive distal bronchial stenosis. Although ischemia has been implicated in its pathogenesis, the role of airway colonization with multidrug-resistant organisms remains incompletely understood.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>We conducted a retrospective, single-center study of lung transplant recipients who developed VBS between January 2001 and November 2025. Clinical characteristics, bronchoscopic findings, microbiological data, and outcomes following airway stenting were reviewed. VBS was defined as progressive bronchial stenosis predominantly involving the distal airway beyond the bronchial anastomosis. Associations between airway infection, stent outcomes, and airway healing were evaluated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 203 lung transplant recipients, five patients (2.5%) developed VBS requiring airway stenting. All patients demonstrated stenosis involving the bronchus intermedius. Multidrug-resistant organisms, including methicillin-resistant Staphylococcus aureus, were detected in two patients, both of whom remained stent-dependent. In contrast, three patients without multidrug-resistant organisms ultimately achieved successful stent removal with sustained airway patency. However, long-term stent dependency was also influenced by persistent structural airway abnormalities and stent-related factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>VBS may involve a complex interplay among ischemic injury, structural airway abnormalities, stent-related factors, and microbial colonization. Persistent multidrug-resistant airway colonization may be associated with unfavorable airway outcomes; however, its independent contribution remains uncertain.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书